Invention Grant
- Patent Title: Spiro-lactam NMDA modulators and methods of using same
-
Application No.: US16781141Application Date: 2020-02-04
-
Publication No.: US11427585B2Publication Date: 2022-08-30
- Inventor: M. Amin Khan
- Applicant: Aptinyx Inc.
- Applicant Address: US IL Evanston
- Assignee: Aptinyx Inc.
- Current Assignee: Aptinyx Inc.
- Current Assignee Address: US IL Evanston
- Agency: Goodwin Procter LLP
- Main IPC: C07D471/10
- IPC: C07D471/10 ; A61K9/00 ; C07D487/10 ; A61P25/28 ; A61P25/02 ; A61P25/22 ; A61P25/18 ; A61P25/24 ; A61P25/06
Abstract:
Disclosed are compounds having potency in the modulation of NMDA receptor activity. Such compounds can be used in the treatment of conditions such as depression and related disorders. Orally delivered formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
Public/Granted literature
- US20210002279A1 SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAME Public/Granted day:2021-01-07
Information query
